27 April 2021 : Case report
A Rare Case of Pembrolizumab-Induced Dermatomyositis in a Patient with Cancer of Unknown Primary Origin
Challenging differential diagnosis, Unusual or unexpected effect of treatment, Diagnostic / therapeutic accidents, Unexpected drug reaction, Rare disease
DOI: 10.12659/AJCR.930286
Am J Case Rep 2021; 22:e930286